INS and metabolic syndrome: To better reflect the underlying pathophysiology of MetS, inflammatory and prethrombotic markers, including insulin levels, plasminogen activator inhibitors, C-reactive protein (CRP), interleukin-6 (IL-6), uric acid (UA) levels, and microalbuminuria (MUA) are considered.